192 related articles for article (PubMed ID: 17010685)
1. Strontium ranelate reduces the urinary level of cartilage degradation biomarker CTX-II in postmenopausal women.
Alexandersen P; Karsdal MA; Qvist P; Reginster JY; Christiansen C
Bone; 2007 Jan; 40(1):218-22. PubMed ID: 17010685
[TBL] [Abstract][Full Text] [Related]
2. Protelos: nonvertebral and hip antifracture efficacy in postmenopausal osteoporosis.
Adami S
Bone; 2006 Feb; 38(2 Suppl 1):23-7. PubMed ID: 16434247
[TBL] [Abstract][Full Text] [Related]
3. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: Results of a five-year, randomized, placebo-controlled trial.
Reginster JY; Felsenberg D; Boonen S; Diez-Perez A; Rizzoli R; Brandi ML; Spector TD; Brixen K; Goemaere S; Cormier C; Balogh A; Delmas PD; Meunier PJ
Arthritis Rheum; 2008 Jun; 58(6):1687-95. PubMed ID: 18512789
[TBL] [Abstract][Full Text] [Related]
4. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
Ortolani S; Vai S
Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319
[TBL] [Abstract][Full Text] [Related]
5. Long-term treatment of postmenopausal osteoporosis with strontium ranelate: results at 8 years.
Reginster JY; Bruyère O; Sawicki A; Roces-Varela A; Fardellone P; Roberts A; Devogelaer JP
Bone; 2009 Dec; 45(6):1059-64. PubMed ID: 19679207
[TBL] [Abstract][Full Text] [Related]
6. A new treatment for post-menopausal osteoporosis: strontium ranelate.
Rizzoli R
J Endocrinol Invest; 2005; 28(8 Suppl):50-7. PubMed ID: 16323829
[TBL] [Abstract][Full Text] [Related]
7. Strontium ranelate effect in postmenopausal women with different clinical levels of osteoarthritis.
Alexandersen P; Karsdal MA; Byrjalsen I; Christiansen C
Climacteric; 2011 Apr; 14(2):236-43. PubMed ID: 20726814
[TBL] [Abstract][Full Text] [Related]
8. The effects of strontium ranelate in Asian women with postmenopausal osteoporosis.
Hwang JS; Chen JF; Yang TS; Wu DJ; Tsai KS; Ho C; Wu CH; Su SL; Wang CJ; Tu ST
Calcif Tissue Int; 2008 Nov; 83(5):308-14. PubMed ID: 18843436
[TBL] [Abstract][Full Text] [Related]
9. [Strontium ranelate: a novel concept for the treatment of osteoporosis].
Dimai HP
Wien Klin Wochenschr; 2005 Nov; 117(21-22):728-38. PubMed ID: 16416353
[TBL] [Abstract][Full Text] [Related]
10. Addressing and meeting the needs of osteoporotic patients with strontium ranelate: a review.
Boonen S
Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S21-7. PubMed ID: 16735842
[TBL] [Abstract][Full Text] [Related]
11. Strontium ranelate: a physiological approach for optimizing bone formation and resorption.
Marie PJ
Bone; 2006 Feb; 38(2 Suppl 1):S10-4. PubMed ID: 16439191
[TBL] [Abstract][Full Text] [Related]
12. Strontium ranelate: a dual mode of action rebalancing bone turnover in favour of bone formation.
Marie PJ
Curr Opin Rheumatol; 2006 Jun; 18 Suppl 1():S11-5. PubMed ID: 16735840
[TBL] [Abstract][Full Text] [Related]
13. Strontium ranelate: a new paradigm in the treatment of osteoporosis.
Reginster JY; Deroisy R; Jupsin I
Drugs Today (Barc); 2003 Feb; 39(2):89-101. PubMed ID: 12698204
[TBL] [Abstract][Full Text] [Related]
14. Effects of strontium ranelate on spinal osteoarthritis progression.
Bruyere O; Delferriere D; Roux C; Wark JD; Spector T; Devogelaer JP; Brixen K; Adami S; Fechtenbaum J; Kolta S; Reginster JY
Ann Rheum Dis; 2008 Mar; 67(3):335-9. PubMed ID: 17965119
[TBL] [Abstract][Full Text] [Related]
15. Strontium ranelate in osteoporosis.
Reginster JY
Curr Pharm Des; 2002; 8(21):1907-16. PubMed ID: 12171530
[TBL] [Abstract][Full Text] [Related]
16. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study.
Reginster JY; Seeman E; De Vernejoul MC; Adami S; Compston J; Phenekos C; Devogelaer JP; Curiel MD; Sawicki A; Goemaere S; Sorensen OH; Felsenberg D; Meunier PJ
J Clin Endocrinol Metab; 2005 May; 90(5):2816-22. PubMed ID: 15728210
[TBL] [Abstract][Full Text] [Related]
17. The effect of strontium ranelate on serum insulin like growth factor-1 and leptin levels in osteoporotic post-menopausal women: a prospective study.
Gulhan I; Bilgili S; Gunaydin R; Gulhan S; Posaci C
Arch Gynecol Obstet; 2008 Nov; 278(5):437-41. PubMed ID: 18322691
[TBL] [Abstract][Full Text] [Related]
18. No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial.
Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Ballaouri I; Efstathiadou Z; Kita M; Avramidis A
Clin Endocrinol (Oxf); 2009 Apr; 70(4):522-6. PubMed ID: 18625000
[TBL] [Abstract][Full Text] [Related]
19. Short-term hemostatic safety of strontium ranelate treatment in elderly women with osteoporosis.
Halil M; Cankurtaran M; Yavuz BB; Ulger Z; Piskinpasa S; Gedik A; Haznedaroglu IC; Kirazli S; Ariogul S
Ann Pharmacother; 2007 Jan; 41(1):41-5. PubMed ID: 17179188
[TBL] [Abstract][Full Text] [Related]
20. Strontium ranelate: a novel treatment in postmenopausal osteoporosis.
Tournis S; Economopoulos D; Lyritis GP
Ann N Y Acad Sci; 2006 Dec; 1092():403-7. PubMed ID: 17308165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
